MCW melanoma cocktail for the evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma

Expert Review of Molecular Diagnostics

Volumn 5, Issue 3, 2005, Pages 281-290

  Shidham, Vinod B ^a   Chang, Chung Che ^b   Komorowski, Richard ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Immunocytochemistry; Intraoperative cytology; MART 1; MCW melanoma cocktail; Melan A; Melanoma; Micrometastasis; Sentinel lymph node; Tyrosinase

Indexed keywords

MELAN A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HMB 45; MONOPHENOL MONOOXYGENASE; PROTEIN S 100;

CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; QUALITY CONTROL; REVIEW; SENTINEL LYMPH NODE BIOPSY;

ANIMALS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 18844439159     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.5.3.281     Document Type: Review

References (49)

1. Salti GI, Das Gupta TK. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. Am. J. Surg. 186, 98-101 (2003).
2. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes - one institution's experience. Melanoma Res. 13, 35-43 (2003).
3. Manca G, Facchetti F, Pizzocaro C et al. Nodal staging in localized melanoma. The experience of the Brescia Melanoma Unit. Br. J. Plast. Surg. 56, 534-539 (2003).
4. Rutkowski P, Nowecki ZI, Nasierowska-Guttmejer A, Ruka W. Lymph node status and survival in cutaneous malignant melanoma-sentinel lymph node biopsy impact. Eur. J. Surg. Oncol. 29, 611-618 (2003).
5. Wagner JD, Ranieri J, Evdokimow DZ et al. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Plast. Reconstr. Surg. 112, 486-497 (2003).
6. Zapas JL, Coley HC, Beam SL, Brown SD, Jablonski KA, Elias EG. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy. J. Am. Coll. Surg. 197, 403-407 (2003).
7. Gad D, Sjogren P. Sentinel lymph node biopsy in patients with cutaneous malignant melanoma 165, 2567-2570 (2003).
8. Kaikaris V, Valiukeviciene S, Rimdeika R, Gollnick H, Ulrich J. Sentinel lymph node biopsy in melanoma patients: methods, indications, and clinical significance Medicina (Kaunas) 39, 621-630 (2003).
9. Arens A, Osinga J, Schwipper V, Schober O, Tilkorn H, Liebau J. Sentinel lymph node dissection in patients with malignant melanoma. Diagnostic and therapeutic standards. Chirurg 74, 665-670 (2003).
10. Santinami M, Baldi M, Tragni G et al. Impact of sentinel lymph node biopsy on the treatment of melanoma Tumori 89(4 Suppl.), 273-275 (2003).
11. Al-Hiari AA, Al-Kaylani H. Sentinel node in management of malignant melanoma. Saudi Med. J. 23, 1462-1465 (2002).
12. Pu LL, Wells KE, Cruse CW, Shons AR, Reintgen DS. Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck. Plast. Reconstr. Surg. 112, 43-49 (2003).
13. Buonomo O, Felici A, Granai AV et al. Sentinel lymphadenectomy in cutaneous melanoma. Tumori 88, S49-S51 (2002).
14. Nieweg OE, Eggermont AM, Kroon BB. Sentinel node biopsy in melanoma: some critical questions. Ned. Tijdschr. Geneeskd. 146, 1774-1777 (2002).
15. Essner R, Cochran AJ. Sentinel node biopsy: not only a staging tool? Recent Results Cancer Res. 160, 133-148 (2002).
16. Thompson JF. The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma. Ann. Surg. Oncol. 8(9 Suppl.), 44S-47S (2001).
17. Medalie NS, Ackerman AB. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: Part I. Am. J. Dermatopathol. 25, 399-417 (2003).
18. Medalie NS, Ackerman AB. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: Part II. Am. J. Dermatopathol. 25, 473-484 (2003).
19. Reintgen DS, Cruse CW, Glass F, Fenske N. In support of sentinel node biopsy as a standard of care for patients with malignant melanoma. Dermatol. Surg. 26, 1070-1072 (2000).
20. Kapteijn BA, Nieweg OE, Liem I et al. Localizing the sentinel node in cutaneous melanoma: γ probe detection versus blue dye. Ann. Surg. Oncol. 4, 156-160 (1997).
21. Shidham VB, Qi D, Rao R et al. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with MCW melanoma cocktail - a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase. BMC Cancer 3(1), 15 (2003). Describes the technical details not covered in this review. May also be referred to for specific data and analysis of results.
22. Qi D, Acker S, Kampalath B, Chang C, Komorowski R, Shidham VB. Detection of melanoma micrometastases in sentinel lymph nodes: evaluation of MART-1 and Melan-A in comparison to traditionally used immunomarkers. Am. J. Clin. Pathol. 114, 629-659 (2000) (Abstract 8).
23. Shidham VB, Qi D, Acker S et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared to S-100 protein and HMB-45. Am. J. Surg. Pathol. 25, 1039-1046 (2001). First in the series.
24. Shidham V, Macias V, Neuberg M et al. Rapid intraoperative immunocytochemical evaluation of cutaneous melanoma sentinel lymph nodes for melanoma metastases with 'MCW Melanoma Cocktail'. Acta Cytol. 47, 938 (2003) (Abstract 191).
25. Shidham VB, Komorowski R, Dawson G, Kaul S, Chang CC, Macias V. Optimization of immunostaining protocol for rapid intraoperative evaluation of imprint smears of melanoma sentinel lymph nodes with 'MCW melanoma cocktail'. CytoJournal 1, 2 (2004). Describes the technical details not covered in this review. May also be referred to for specific data and analysis of results.
26. Gibbs JF, Huang PP, Zhang PJ, Kraybill WG, Cheney R. Accuracy of pathologic techniques for the diagnosis of metastatic melasnoma in sentinel lymph nodes. Ann. Surg. Oncol. 6, 699-704 (1999).
27. Clary BM, Lewis JJ, Brady MS, Busam K, Coit DG. Should frozen section analysis of the sentinel node be performed in patients with melanoma? Eur. J. Nucl. Med. 26, S68 (1999).
28. Tanis PJ, Boom RP, Koops HS et al. Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann. Surg. Oncol. 8, 222-226 (2001).
29. Creager AJ, Shiver SA, Shen P, Geisinger KR, Levine EA. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer 94, 3016-3022 (2002).
30. Hocevat M, Bracko M, Pogacnik A, Vidergar-Kralj B, Besic N, Zgajnar J. Role of imprint cytology in the intraoperative evaluation of sentinel lymph nodes for malignant melanoma. Eur. J. Cancer 39, 2173-2178 (2003).
31. Eudy GE, Carlson GW, Murray DR, Waldrop SM, Lawson D, Cohen C. Rapid immunohistochemistry of sentinel lymph nodes for metastatic melanoma. Hum. Pathol. 34, 797-802 (2003).
32. Cochran AJ. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am. J. Surg. Pathol. 2310, 1169-1172 (1999).
33. Shidham VB, Susnik B, Rao RN, Chivukula M, Kampalath B, Komorowski R. HMB45 immunoreactive single cells in sentinel lymph nodes negative for melanoma micrometastases are mast cells. Mod. Pathol. 17(Suppl. 1), 1a-388a (2004) (Abstract 1528).
34. Mahmood MN, Lee MW, Linden MD, Nathanson SD, Hornyak TJ, Zarbo RJ. Diagnostic value of HMB-45 and antiMelan A staining of sentinel lymph nodes with isolated positive cells. Mod. Pathol. 15(12), 1288-1293 (2002).
35. Jungbluth AA, Iverson K, Coplan K et al. T311 - an antityrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues. Pathol. Res. Pract. 196(4), 235-242 (2000).
36. Miettinen M, Fernandez M, Franssila K, Gatalica Z, Lasota J, Sarlomo-Rikala M. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am. J. Surg. Pathol. 25, 205-211 (2001).
37. Yu LL, Flotte TJ, Tanabe KK et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86, 617-627 (1999).
38. Blaheta HJ, Ellwanger U, Schittek B et al. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. J. Invest. Dermatol. 114, 637-642 (2000).
39. Blaheta HJ, Paul T, Sotlar K et al. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Br. J. Dermatol. 145, 195-202 (2001).
40. Ghossein R, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 78, 10-16 (1996).
41. Ribe A, McNutt NS. S100A6 protein expression is different in Spitz nevi and melanomas. Mod. Pathol. 16(5), 505-511 (2003).
42. Shivers SC, Wang X, Li W et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 280, 1410-1415 (1998).
43. Sung J, Li W, Shivers S, Reintgen D. Molecular analysis in evaluating the sentinel node in malignant melanoma. Ann. Surg. Oncol. 8(9 Suppl.), 29S-30S (2001).
44. Shidham VB, Chang CC, Rao RN, Komorowski R, Chivukula M. Immunostaining of cytology smears: a comparative study to identify the most suitable method of smear preparation and fixation with reference to commonly used immunomarkers. Diagn. Cytopathol. 29, 217-221 (2003).
45. Shidham V, Kampalath B, England J. Routine air drying of all the smears prepared during fine needle aspiration and intraoperative cytology studies: an opportunity to practice a unified protocol, offering the flexibility of choosing variety of staining methods. Acta Cytol. 45, 60-68 (2001).
46. Yan S, Brennick JB. False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes. Am. J. Surg. Pathol. 28(5), 596-600 (2004).
47. CPT Editorial Panel. Current Procedural Terminology, CPT2004, American Medical Association, IL, USA, 319-323 (2003).
48. Treseler PA, Tauchi PS. Sentinel lymph nodes in human solid cancer. Pathologic analysis of the sentinel lymph node. Surg. Clin. North. Am. 80, 1695-1619 (2000).
49. Shidham VB, Dravid NV, Grover S, Kher AV. Role of scrape cytology in rapid intra-operative diagnosis - value and limitations. Acta Cytol. 28, 477 (1984).